ARTICLE | Company News
University of Minnesota, Amal Therapeutics deal
November 16, 2015 8:00 AM UTC
The university granted Amal exclusive rights to a patent covering the use of a peptide with immunostimulatory properties when used as an adjuvant for cancer vaccines. The partners did not respond to i...